View in EDS HTML Full Text PDF Full Text

Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.

Saved in:
Bibliographic Details
Title: Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
Authors: Wang G; Washington University St Louis School of Medicine St. Louis Missouri USA., Li Y; Washington University St Louis School of Medicine St. Louis Missouri USA., Xiong C; Washington University St Louis School of Medicine St. Louis Missouri USA., McDade E; Washington University St Louis School of Medicine St. Louis Missouri USA., Clifford DB; Washington University St Louis School of Medicine St. Louis Missouri USA., Mills SL; Washington University St Louis School of Medicine St. Louis Missouri USA., Santacruz AM; Washington University St Louis School of Medicine St. Louis Missouri USA., Aschenbrenner AJ; Washington University St Louis School of Medicine St. Louis Missouri USA., Hassenstab J; Washington University St Louis School of Medicine St. Louis Missouri USA., Benzinger TLS; Washington University St Louis School of Medicine St. Louis Missouri USA., Gordon BA; Washington University St Louis School of Medicine St. Louis Missouri USA., Fagan AM; Washington University St Louis School of Medicine St. Louis Missouri USA., Coalier KA; Washington University St Louis School of Medicine St. Louis Missouri USA., Libre-Guerra JJ; Washington University St Louis School of Medicine St. Louis Missouri USA., McCullough A; Washington University St Louis School of Medicine St. Louis Missouri USA., Joseph-Mathurin N; Washington University St Louis School of Medicine St. Louis Missouri USA., Chen CD; Washington University St Louis School of Medicine St. Louis Missouri USA., Mummery C; University College London London UK., Wendelberger BA; Berry Consultants LLC Austin Texas USA., Gauthier S; McGill University Centre for Studies on Aging in Montreal Montreal Quebec Canada., Masellis M; University of Toronto Sunnybrook Health Sciences Centre Toronto Ontario Canada., Holdridge KC; Eli Lilly and Company Indianapolis Indiana USA., Yaari R; Eli Lilly and Company Indianapolis Indiana USA., Chatterjee S; Eli Lilly and Company Indianapolis Indiana USA., Sims J; Eli Lilly and Company Indianapolis Indiana USA., Delmar P; F. Hoffmann-La Roche, Ltd. Basel Switzerland., Kerchner GA; F. Hoffmann-La Roche, Ltd. Basel Switzerland., Bittner T; F. Hoffmann-La Roche, Ltd. Basel Switzerland., Hofmann C; F. Hoffmann-La Roche, Ltd. Basel Switzerland., Bateman RJ; Washington University St Louis School of Medicine St. Louis Missouri USA.
Corporate Authors: DIAN‐TU Study Team
Source: Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2022 Nov 03; Vol. 14 (1), pp. e12367. Date of Electronic Publication: 2022 Nov 03 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101654604 Publication Model: eCollection Cited Medium: Print ISSN: 2352-8729 (Print) Linking ISSN: 23528729 NLM ISO Abbreviation: Alzheimers Dement (Amst) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36348972
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+G%22">Wang G</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Xiong+C%22">Xiong C</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22McDade+E%22">McDade E</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Clifford+DB%22">Clifford DB</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Mills+SL%22">Mills SL</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Santacruz+AM%22">Santacruz AM</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Aschenbrenner+AJ%22">Aschenbrenner AJ</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Hassenstab+J%22">Hassenstab J</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Benzinger+TLS%22">Benzinger TLS</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Gordon+BA%22">Gordon BA</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Fagan+AM%22">Fagan AM</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Coalier+KA%22">Coalier KA</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Libre-Guerra+JJ%22">Libre-Guerra JJ</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22McCullough+A%22">McCullough A</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Joseph-Mathurin+N%22">Joseph-Mathurin N</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Chen+CD%22">Chen CD</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.<br /><searchLink fieldCode="AU" term="%22Mummery+C%22">Mummery C</searchLink>; University College London London UK.<br /><searchLink fieldCode="AU" term="%22Wendelberger+BA%22">Wendelberger BA</searchLink>; Berry Consultants LLC Austin Texas USA.<br /><searchLink fieldCode="AU" term="%22Gauthier+S%22">Gauthier S</searchLink>; McGill University Centre for Studies on Aging in Montreal Montreal Quebec Canada.<br /><searchLink fieldCode="AU" term="%22Masellis+M%22">Masellis M</searchLink>; University of Toronto Sunnybrook Health Sciences Centre Toronto Ontario Canada.<br /><searchLink fieldCode="AU" term="%22Holdridge+KC%22">Holdridge KC</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Yaari+R%22">Yaari R</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Chatterjee+S%22">Chatterjee S</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Sims+J%22">Sims J</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Delmar+P%22">Delmar P</searchLink>; F. Hoffmann-La Roche, Ltd. Basel Switzerland.<br /><searchLink fieldCode="AU" term="%22Kerchner+GA%22">Kerchner GA</searchLink>; F. Hoffmann-La Roche, Ltd. Basel Switzerland.<br /><searchLink fieldCode="AU" term="%22Bittner+T%22">Bittner T</searchLink>; F. Hoffmann-La Roche, Ltd. Basel Switzerland.<br /><searchLink fieldCode="AU" term="%22Hofmann+C%22">Hofmann C</searchLink>; F. Hoffmann-La Roche, Ltd. Basel Switzerland.<br /><searchLink fieldCode="AU" term="%22Bateman+RJ%22">Bateman RJ</searchLink>; Washington University St Louis School of Medicine St. Louis Missouri USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22DIAN‐TU+Study+Team%22">DIAN‐TU Study Team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101654604%22">Alzheimer's & dementia (Amsterdam, Netherlands)</searchLink> [Alzheimers Dement (Amst)] 2022 Nov 03; Vol. 14 (1), pp. e12367. <i>Date of Electronic Publication: </i>2022 Nov 03 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+on+behalf+of+the+Alzheimer's+Association%22">Wiley on behalf of the Alzheimer's Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101654604 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2352-8729 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223528729%22">23528729 </searchLink><i>NLM ISO Abbreviation: </i>Alzheimers Dement (Amst) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36348972
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/dad2.12367
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e12367
    Titles:
      – TitleFull: Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang G
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Xiong C
      – PersonEntity:
          Name:
            NameFull: McDade E
      – PersonEntity:
          Name:
            NameFull: Clifford DB
      – PersonEntity:
          Name:
            NameFull: Mills SL
      – PersonEntity:
          Name:
            NameFull: Santacruz AM
      – PersonEntity:
          Name:
            NameFull: Aschenbrenner AJ
      – PersonEntity:
          Name:
            NameFull: Hassenstab J
      – PersonEntity:
          Name:
            NameFull: Benzinger TLS
      – PersonEntity:
          Name:
            NameFull: Gordon BA
      – PersonEntity:
          Name:
            NameFull: Fagan AM
      – PersonEntity:
          Name:
            NameFull: Coalier KA
      – PersonEntity:
          Name:
            NameFull: Libre-Guerra JJ
      – PersonEntity:
          Name:
            NameFull: McCullough A
      – PersonEntity:
          Name:
            NameFull: Joseph-Mathurin N
      – PersonEntity:
          Name:
            NameFull: Chen CD
      – PersonEntity:
          Name:
            NameFull: Mummery C
      – PersonEntity:
          Name:
            NameFull: Wendelberger BA
      – PersonEntity:
          Name:
            NameFull: Gauthier S
      – PersonEntity:
          Name:
            NameFull: Masellis M
      – PersonEntity:
          Name:
            NameFull: Holdridge KC
      – PersonEntity:
          Name:
            NameFull: Yaari R
      – PersonEntity:
          Name:
            NameFull: Chatterjee S
      – PersonEntity:
          Name:
            NameFull: Sims J
      – PersonEntity:
          Name:
            NameFull: Delmar P
      – PersonEntity:
          Name:
            NameFull: Kerchner GA
      – PersonEntity:
          Name:
            NameFull: Bittner T
      – PersonEntity:
          Name:
            NameFull: Hofmann C
      – PersonEntity:
          Name:
            NameFull: Bateman RJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 11
              Text: 2022 Nov 03
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2352-8729
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Alzheimer's & dementia (Amsterdam, Netherlands)
              Type: main
ResultId 1